|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular |
1 Institut für Pharmakologie und Toxikologie
2 Institut für Molekulare Medizin, TU München, Biedersteiner Strasse 29, D-80802 München, Germany
| Abstract |
|---|
|
|
|---|
(Received 24 November 2005;
accepted after revision 28 February 2006;
first published online 2 March 2006)
Corresponding author A. Welling: Institut für Pharmakologie und Toxikologie, TU München, Biedersteiner Strasse 29, D-80802 München, Germany. Email: welling{at}ipt.med.tu-muenchen.de
| Introduction |
|---|
|
|
|---|
-conotoxin MVIIC or
-agatoxin IVA reduced ICa of wild-type islets by 97%, demonstrating the presence of both L- and non-L-type channels (Schulla et al. 2003). In agreement with this result, studies on CaV2.3/ islets and mice suggested that CaV2.3 is responsible for the second phase of insulin secretion (Jing et al. 2005). A study on CaV2.2-deficient mice revealed an increased glucose tolerance and a reduced weight gain on a high-fat diet (Takahashi et al. 2005).
In A-cells, low blood glucose levels enhance [Ca2+]i followed by glucagon secretion. The mechanisms coupling low blood sugar levels to glucagon secretion are unknown (Gromada et al. 1997). It was speculated that low-voltage-activated (LVA) T-type calcium channels could be key regulators, depolarizing the membrane to potentials necessary to activate high-voltage-activated (HVA) calcium channels (Gopel et al. 2000). T-type channel expression in pancreatic islet cells is species dependent, with little or no expression in rodents, but it is readily detectable in humans (Perez-Reyes, 2003; Yang & Berggren, 2005). Others reported that KATP channels and the inactivation of TTX-sensitive Na+ channels regulated glucagon release (Bokvist et al. 1999; Gopel et al. 2000). Two types of TTX-sensitive sodium channels have been distinguished in islet cells according to their voltage dependence. B-cells have a voltage-dependent sodium current (Pressel & Misler, 1990) which, owing to the voltage dependence of inactivation, is unlikely to play a major role in glucose-induced electrical activity (Plant, 1988). A-cells possess a prominent TTX-sensitive sodium current, which is activated at physiological membrane potentials (Gopel et al. 1999; Barg et al. 2000). Six different genes (NaV1.1, NaV1.2, NaV1.3, NaV1.4, NaV1.6 and NaV1.7) coding for TTX-sensitive sodium channel
-subunits have been described (Goldin et al. 2000). Yet the molecular background for the sodium channel currents in islet cells is unknown.
In the present study, the expression of different calcium channels and TTX-sensitive sodium channels was analysed in A- and B-cells of the mouse by patch-clamp, specific blocker, PCR and single-cell RT-PCR. A- and B-cells were clearly identified by RT-PCR using insulin- and glucagon-specific primers.
| Methods |
|---|
|
|
|---|
Materials
Unless otherwise noted the materials were obtained from Sigma and were of the highest purity available. The snail venom
-conotoxin GVIA and the spider venoms
-agatoxin IVA and SNX 482 were obtained from Alomone Laboratories (Jerusalem, Israel). A 20 µM stock solution of the P/Q-type calcium channel blocker
-agatoxin IVA was prepared in destilled water and diluted in extracellular solution to a final concentration of 0.2 µM. An 82 µM stock solution of the N-type calcium channel blocker
-conotoxin GVIA was prepared in destilled water and diluted in extracellular solution to a final concentration of 1.6 µM. A 10 µM stock solution of the R-type calcium channel blocker SNX 482 was prepared in destilled water and diluted in extracellular solution to a final concentration of 0.1 µM. The dihydropyridine (DHP) isradipine (Pfizer) was prepared as a 10 mM stock solution in ethanol and diluted in extracellular solution to the indicated concentrations. The Na+ channel blocker TTX was prepared as a 1 mM stock in distilled H2O and used in a final concentration of 0.1 µM.
Generation of ßCaV1.2/ mice
The generation and maintaining of the mice was described earlier (Schulla et al. 2003). The mice lack the L-type calcium channel
1-subunit CaV1.2 specifically in B-cells.
Generation of
CaV1.2/ mice
To generate A-cell-specific CaV1.2-deficient mice, the CaV1.2+/L2 mouse carrying one L2 allele and one wild-type allele (Seisenberger et al. 2000; Schulla et al. 2003) was crossed with a mouse expressing the Cre (cyclization recombination)-recombinase under the control of the rat glucagon promotor (GlucCre+/tg; Herrera, 2000). The resulting CaV1.2+/L2GlucCre+/tg mice were mated with CaV1.2L2/L2 mice homozygous for the L2 allele. The A-cell-specific knockout CaV1.2L2/L2GlucCre+/tg (
CaV1.2/) mice and control animals CaV1.2+/L2GlucCre+/tg (
CaV1.2+/) were obtained. Genotyping was performed using primers ag2 (
5'-CTGCTAACCATGTTCATGCCT-3'), Cre1 (
5'-CCTGTTTTGCACCG-3') and Cre3 (
5'-ATGCTTCTGTCCGTTTGCCG-3'). The background mouse strain was C57BL/6(6J).
Isolation of pancreatic islets and single islet cells
Wild-type, control or different knockout mice were killed by cervical dislocation and the pancreas was quickly removed. Pancreatic islets were isolated by a standard collagenase digestion (Barg et al. 2001; Schulla et al. 2003). Islets were transferred to plastic coverslips in a 24-well plate, and single islet cells were obtained by shaking the islets in Ca2+-free solution. Cells were allowed to attach to the coverslips overnight.
DNA isolation and PCR analysis
Genomic DNA from islet or heart tissue was isolated using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany). Briefly, the tissue was incubated overnight at 56°C in 180 µl ATL tissue lysis buffer plus 20 µl Proteinase K. The digest was purified with a QIAamp Spin Column and eluted with 100 µl buffer. Two microlitres were used for PCR analysis using the CaV1.2-specific primers VI4, VI8 and VI10 (Schulla et al. 2003).
RT-PCR on mRNA of islets
Freshly prepared islets were cultured overnight in RPMI 1640 medium (GibcoTM) at 37°C. PolyA mRNA was isolated using Dynabeads Oligo (dT)25 (Dynal Biotech, Oslo, Norway). The following buffers were used: GTC buffer [4 M guanidine thiocyanate, 20 mM sodium acetate (pH 5.4), 0.1 mM dithiothreitol, 0.5% lauroyl sarcosinat (w/v), 6.5 ml ml1 mercaptoethanol], binding buffer (100 mM Tris-HCl pH 8.0, 20 mM EDTA, 400 mM LiCl) and washing buffer (10 mM Tris-HCl pH 8.0, 0.15 M LiCl, 1 mM EDTA). The mRNA was eluted with diethylpyrocarbonate (DEPC)-treated water. Random hexamer primers and Superscript Reverse Transkriptase II (LifeTechnologies) were used for cDNA synthesis (Schulla et al. 2003). To distinguish glucagon-producing A- from insulin-producing B-cells, intron-spanning specific primer pairs were designed from sequences of the mouse insulin and gucagon gene, respectively (Table 1). For the amplification of the LVA calcium channels, degenerated primers, which bind to every known LVA calcium channel (CaV3.1, CaV3.2 and CaV3.3) were used, followed by a nested PCR with specific primers for each LVA calcium channel. For the amplification of the TTX-sensitive sodium channels, primers were designed from the appropriate mouse genes. A standard PCR protocol was used with optimal temperatures for every primer pair. Table 2 summarizes the primer pairs used for the amplification of HVA calcium channels (1), LVA calcium channels with degenerated primers (2) and with specific primers (3), and TTX-sensitive sodium channels (4).
|
|
Following recording, the single islet cells were aspirated with fine borosilicate glass pipettes and stored in a PCR tube with 1820 µl 1x standard PCR buffer at 80°C after quick freezing in liquid nitrogen. An OneStep RT-PCR protocol (Qiagen) was used to check for the expression of the different ion channels in single islet cells and to distinguish glucagon-producing A- from insulin-producing B-cells. The cells were thawed and handled according to the protocol of the manufacturer. The reaction kit consisted of: RNase-free water, 5x Qiagen OneStep RT-PCR buffer, dNTP mix (containing 10 mM of each dNTP) and Qiagen OneStep RT-PCR enzyme mix (including Omniscript and Sensiscript reverse transcriptase and HotStarTaq polymerase). The RNase inhibitor RNasin Plus (Promega) was used to avoid any damage of the mRNA, and the appropriate primer pairs were added at a final concentration of 0.6 µM to the reaction mix. The reactions were amplified for 30 or 40 cycles. The PCR products were examined on a 2% agarose gel.
Electrophysiology
Currents were recorded at room temperature from single islet cells using the standard whole-cell technique. The measurements were performed using an EPC-9 patch-clamp amplifier (HEKA Electronics, Lambrecht/Pflaz, Germany) and Pulse (version 8.54) software. Currents were compensated for capacitive transients with the built-in compensation. No leak compensation was done. Patch pipettes were pulled from borosilicate glass with a resistance of 2.84.0 M
when filled with the pipette solution. The pipette solution contained (mM): 125 CsCl, 1 MgCl2, 10 EGTA, 3 Mg2ATP and 10 Hepes, pH 7.15. The standard extracellular medium consisted of (mM): 118 NaCl, 20 tetraethylammonium-Cl (TEA-Cl), 5.6 KCl, 1.2 MgCl2, 5 Hepes and either 2.6 CaCl2 or BaCl2, pH 7.4.
The steady-state inactivation properties of sodium currents were studied using a conventional two-pulse protocol in which a 50 ms test depolarization to 10 or 0 mV was preceded by a 500 ms conditioning pulse (Vpre) to voltages between 150 and 30 mV or between 100 and 10 mV. Data for steady-state inactivation were fitted by a Boltzmann equation:
|
|
Data analysis
The electrophysiological data were analysed with Origin 6.1 (OriginalLab Corp., Northampton, MA, USA). Data are given as mean values ±S.E.M. Statistical significances were evaluated by unpaired Student's t test.
| Results |
|---|
|
|
|---|
A-cells are easily lost during the preparation process. Therefore, most of the washing steps were omitted and, after the enzyme treatment, islets were transferred directly to coverslips in a 24-well plate. They were shaken in the 24-well plate to obtain single A- and B-cells. The next day the coverslips were transferred to the recording chamber. After the recording, single cells were aspirated with a fine borosilicate glass pipette and transferred to a PCR tube containing ice-cold PCR buffer. The tubes were stored at 80°C. A standard RT-PCR protocol was used with insulin- and glucagon-specific primers, which resulted in amplicons of 344 and 493 bp (Fig. 1A). Sequencing confirmed the correct identity of the amplified products. The identification process for A-cells was further substantiated by using islet cells from ßCaV1.2/ mice (Schulla et al. 2003). These mice lack the CaV1.2 L-type calcium channel only in B-cells. The L-type calcium current was inhibited by 1 µM isradipine, and subsequently the cells were genotyped by RT-PCR with insulin- and glugacon-specific primers. Fifteen out of 21 DHP-sensitive cells showed the 493 bp glucagon band. Fourteen of the DHP-insensitive cells were tested; all of them lacked the glucagon band. Thus, the expression of the glugacon band is sufficient to distinguish A- from B-cells. Altogether, 79 (54%) out of 145 cells were genotyped as B-cells and 42 (29%) as A-cells. The remaining cells (17%) could be D- or F-cells, although it cannot be excluded that the genotyping of some of these cells failed.
|
The expression of T-type calcium channels in pancreatic islets of the mouse was investigated by PCR analysis with a standard PCR protocol with degenerated primers for all T-type calcium channels (T05 (5') and T06 (3')) followed by a nested PCR with specific primers for CaV3.1, CaV3.2 and CaV3.3 (Table 2). Amplicons for each of the three LVA calcium channels were found in complete mouse islet cDNA (Fig. 1B) and in a single islet (Fig. 1E). Islets were dissociated into single cells by shaking in Ca2+-free medium. Although the cycle number was increased up to 40, no transcripts for CaV3.1, CaV3.2 or CaV3.3 were found in 47 islet cells analysed by single-cell RT-PCR and nested PCR (see also supplementary Fig. 1).
The expression of T-type calcium channels was studied further by whole-cell patch-clamp recordings in single isolated islet cells. Experiments were done in the presence of 0.1 µM TTX in the bath solution to inhibit sodium currents and with 2.6 mM Ba2+ as the charge carrier. Potassium channels were blocked using 20 mM TEA-Cl in the bath solution plus 125 mM CsCl instead of KCl in the pipette solution. In A-cells, only HVA currents could be seen in single-current traces elicited by depolarizing pulses from a holding potential (Vh) of 100 or 80 mV to voltages from 80 to +10 mV. Similar results were found in B-cells (Fig. 1C and D). In neuronal and other T-type-expressing cells the LVA component appears as a hump on the back of a larger HVA component in the IV relationship. This hump was not found in IV relationships from A- or B-cells. It was postulated that the LVA currents were hidden by the large HVA currents. T-type calcium channels inactivate at lower membrane potentials than L- and non-L-type channels (Bean, 1985). The activity of both channels was recorded from a hyperpolarized potential of 100 or 80 mV. Thereafter, the activity of HVA currents was measured at a Vh of 40 mV, where T-type but not HVA channels are inactivated. The HVA currents were subtracted from the currents at hyperpolarized potentials to isolate the T-type current. Subtraction of every single-current trace elicited from a Vh of 40 mV from the corresponding current trace elicited from a Vh of 100 or 80 mV showed that negative to 40 mV no inward current was detectable. The same results were found in B-cells. Currentvoltage relationships for the currents elicited at Vh80 mV, Vh40 mV and the difference currents were drawn. They differed only in the current amplitude but not in the voltage dependence. Still no hump and thus no T-type was found. After the experiment the cells were further analysed by single-cell RT-PCR with insulin- and glucagon-specific primers. Nine cells were identified as A-cells and 21 as B-cells. None of them showed the hump in the individual IV relationship. Figure 1C shows a representative example for an A-cell. Figure 1D summarizes the data on B-cells (for Vh80 versus40 mV). To confirm the result, single cells from ßCaV1.2/ islets were isolated and identified electrophysiologically by their isradipine sensitivity. Seven A- and 16 B-cells were subsequently analysed by single-cell RT-PCR with CaV3.1-, CaV3.2- and CaV3.3-specific primers. Transcripts could not be amplified in any of them with any primer pair. A representative result for an A-cell is shown in Fig. 1F. Thus, we conclude that LVA calcium channels are absent in pancreatic islet A- and B-cells of the mouse.
Molecular and electrophysiological characterization of TTX-sensitive sodium channels
Similar to the experiments on LVA calcium channels, TTX-sensitive sodium channels were analysed by PCR in whole islet tissue. Specific primers for all known TTX-sensitive sodium channels (NaV1.1, NaV1.2, NaV1.3, NaV1.4, NaV1.6 and NaV1.7) were designed and used with a standard PCR protocol (Table 2). The primers were tested on brain and skeletal muscle cDNA from the mouse. High copy numbers of NaV1.1, NaV1.2, NaV1.3, NaV1.6 and NaV1.7 were identified in the brain cDNA, and amplicons for NaV1.4 and NaV1.2 were found in skeletal muscle. Using optimized temperature for each primer pair, amplicons for NaV1.1, NaV1.3, NaV1.7 and a tiny band of NaV1.6 were detected in complete mouse islet cDNA (Fig. 2A). In single cells, only transcripts for the NaV1.7 could be clearly amplified, although the cycle number was increased up to 40 (Fig. 2B).
|
The cells were genotyped by single-cell RT-PCR with insulin- and glucagon-specific primers. The result was highly surprising. Nine out of 23 cells which showed a sodium current at a holding potential of 120 mV were identified as A-cells, and 14 were recognized as B-cells. The 24 cells that showed the residual sodium current were identified without exception as B-cells (Fig. 2F). Thus, murine A-cells express only the early inactivating sodium current. B-cells can be divided in two populations: 37% of the cells express only the early inactivating sodium channel, and the other 63% express the residual or both types of sodium channels. Single-cell RT-PCR was performed with NaV1.7- and NaV1.3-specific primers. NaV1.7 was identified in cells expressing early inactivating and residual current (5 of 10 cells) as well as in cells with only early inactivating current (8 of 10 cells). Amplicons were not detected in each lane, but it cannot be excluded that this is due to the complexity of the single-cell RT-PCR.
Molecular and electrophysiological characterization of HVA calcium channels
High-voltage-activated calcium channels of islets tissue were analysed by PCR. Specific primer pairs (Table 2) were used to identify amplicons for CaV1.1, CaV1.2, CaV1.3, CaV2.1, CaV2.2 and CaV2.3. CaV1.4 was not analysed because this channel is only expressed in the retina and in T-lymphocytes (Bech-Hansen et al. 1998; Strom et al. 1998; Kotturi & Jefferies, 2005). The primers were tested on brain cDNA from the mouse with a standard PCR protocol (not shown). Amplicons for CaV1.2, CaV1.3, CaV2.1, CaV2.2 and CaV2.3 were detected in complete mouse islet cDNA (Fig. 3A) and in single islet cells (Fig. 3B). Electrophysiological experiments were done with standard pipette and bath solutions in the presence of 0.1 µM TTX, with 2.6 mM Ba2+ as the charge carrier. Potassium channels were blocked using 20 mM TEA-Cl in the bath solution plus 125 mM CsCl instead of KCl in the pipette solution. After the experiments, the cells were genotyped by single-cell RT-PCR with insulin- and glucagon-specific primers. In wild-type and control
CaV1.2+/ A- and B-cells, maximal calcium current amplitudes of 138 ± 16 (n= 28) and 106 ± 12 pA (n= 31), respectively, were measured from a Vh of 100 mV. On average, A-cells were smaller than B-cells with mean cell capacitances of 4.4 ± 0.6 (n= 28) versus 5.8 ± 0.4 pF (n= 31; P < 0.05). The difference was significant because a large number of cells were averaged, but when individual cells were measured it was difficult to identify them as an A- or a B cell by their capacitance only. Owing to the smaller size of the A-cells, their mean calcium current density was significantly higher compared to that of the B-cells (37 ± 4.4 versus22 ± 3.2 pA pF1).
|
We used islet cells from ßCaV1.2/ mice to validate this interpretation (see supplementary Fig. 2). The Ba2+ current of 20 cells from four different ßCaV1.2/ pancreatic islet preparations was tested for its isradipine sensitivity. After the patch-clamp experiment, single-cell RT-PCR was done with the CaV1.3-specific primers. Isradipine (1 µM) had no effect in 15 cells; in nine of these cells no transcripts for CaV1.3 were found, whereas in six cells CaV1.3 mRNA was detected. The averaged cell capacitances were 7.9 ± 1.4 and 7.4 ± 0.7 pF for the cells without and with transcripts, respectively, suggesting that the cells were B-cells. These results indicate that some B-cells have CaV1.3 mRNA without expressing a functional protein. The IBa of five cells was blocked by isradipine. The mean inhibition was 60 ± 7.6%, and the mean cell capacitance 4.6 ± 0.7 pF, suggesting that the cells were A-cells. These cells contained CaV1.3 transcripts.
We used islet cells from
CaV1.2/ mice to confirm that IBa through CaV1.3 channels was only found in A-cells. A-cell-specific Cre/loxP recombination was achieved by expressing the Cre-recombinase under the control of the rat glucagon promotor (Herrera, 2000). The cell specificity of the Cre-recombinase was ascertained by PCR analysis using DNA isolated from islets of control and
CaV1.2/ mice (Fig. 3D). The islets of
CaV1.2/ mice still contain high amounts of the floxed CaV1.2 gene (L2 allele), because most of the islet cells are B-cells, which do not express the glucagon promotor. No Cre-mediated recombination was detectable in heart (Fig. 3D). Mice were viable and fertile and showed no gross abnormalities. Electrophysiological experiments showed that the IBa density of islet cells was decreased from 37 ± 4.4 pA pF1 (n= 28) in wild-type to 19 ± 2.0 pA pF1 (n= 34) in
CaV1.2/ mice. Isradipine (1 µM) reduced IBa of both wild-type and
CaV1.2/ A-cells to similar values of 8.9 ± 2.6 (n= 5) and 6.5 ± 1.0 pA pF1(n= 16), respectively (Fig. 3E). In
CaV1.2/ B-cells, IBa current density and isradipine inhibition were similar to those obtained in wild-type and
CaV1.2+/ B-cells.
The concentrationinhibition curve showed that about 40% of IBa in wild-type islet cells is an isradipine-resistant current that must be caused by non-L-type calcium channels, like CaV2.1, CaV2.2 or CaV2.3. The peptide neurotoxin
-agatoxin IVA is a selective inhibitor of P/Q-type calcium currents. The affinity depends on the splice form of the CaV2.1 channel (P- or Q-type) and the ß-subunit (Moreno et al. 1997; Bourinet et al. 1999). In A- and B-cells,
-agatoxin IVA exerted similar effects on IBa.
-Agatoxin IVA (200 nM) inhibited 16.1 ± 4.4% in A- and 15.5 ± 3.2% of IBa in B-cells (Fig. 4A). N-type Ca2+ channels can be specifically and irreversibly inhibited by
-conotoxin GVIA (Olivera et al. 1984; McCleskey et al. 1987). In B-cells, 1.6 µM of the toxin irreversibly eliminated 15.1 ± 2.4% of IBa (Fig. 4B). The same concentration of
-conotoxin GVIA was without effect in A-cells. Thus, it was concluded that mouse pancreatic A-cells do not express CaV2.2 calcium channels. We used SNX 482, the recently described potent and selective blocker of R-type calcium currents (Newcomb et al. 1998), to test for the expression of CaV2.3 calcium channels in islet cells. SNX 482 (100 nM) blocked 30 ± 4% of IBa in A-cells and 18.1 ± 1.8% of IBa in B-cells (Fig. 4C). The results are summarized in Fig. 5. The total amount of IBa blocked by the different L- and non-L-type calcium channel blockers was 104% in A-cells and 108% in B-cells.
|
|
| Discussion |
|---|
|
|
|---|
Electrophysiological and molecular studies have identified multiple types of L- and non-L-type channel isoforms in islet cells and insulin-secreting cell lines (for review see Satin, 2000; Mears, 2004; Yang & Berggren, 2005). Most of the studies were rather indirect, using whole-animal or whole-islet assays. Electrophysiological studies were hampered by the fact that islet cells could not be clearly identified as A- or B-cells. Therefore, a clear allocation of the different voltage-dependent ion channels has not been possible to date. In our studies, we combined electrophysiological and pharmacological experiments with PCR and single-cell RT-PCR. Some results were substantiated by the utilization of
CaV1.2/ and ßCaV1.2/ mice. Thus, it could be shown that A- and B-cells of the mouse are equipped with different calcium channels. In both A- and B-cells, 60% of the IBa is carried by L-type calcium channels. In B-cells only CaV1.2 current was identified, whereas in A-cells CaV1.2 and CaV1.3 currents are expressed. This could explain why it was believed previously that CaV1.3 represents the major L-type calcium channel in pancreatic islet cells (Iwashima et al. 1993; Seino, 1995; Safayhi et al. 1997; Yang et al. 1999). A- and B-cells also differ in the expression of non-L-type HVA calcium channels. In B-cells, similar fractions (about 15% each) of CaV2.1, CaV2.2 and CaV2.3 currents were found. In A-cells, 30% of the current runs through CaV2.3 and the remaining current traverses via CaV2.1. CaV2.2 current was absent in A-cells. Since the calculated and measured total inhibition of calcium currents in mouse A- and B-cells is complete or even exceeds 100%, we can exclude the possibility that additional HVA calcium channels are expressed in both cell types.
Our experiments clearly show that single pancreatic A- and B-cells of the mouse do not express any T-Type calcium current or T-Type calcium channel mRNA, whereas amplicons for each of the three LVA calcium channel subtypes could be found in whole islet cDNA. Two types of sodium current were detected, an early inactivating and a residual current, but the expression pattern was different from that described earlier (Gopel et al. 1999; Barg et al. 2000). In single A-cells, only the early inactivating type of current was found. B-cells could be devided into two populations: 40% of the B-cells only showed the early inactivating current, whereas the remaining 60% had an additional residual current. Thus 45% of the cells expressing exclusively the early inactivating current are A-cells. NaV1.7 mRNA was identified in both A- and B-cells by single-cell RT-PCR.
Comparison of the present results with other studies
Our results on L-type calcium channels are in agreement with earlier studies in different knockout mice. It has been shown that deletion of CaV1.3 in mice is without effect on serum glucose and insulin levels (Platzer et al. 2000). Accordingly, Schulla et al. (2003) showed that after selective disruption of CaV1.2 in mouse pancreatic B-cells, the entire DHP-sensitive Ca2+ current and the first phase of insulin secretion were lost. These results were confirmed by the use of the CaV1.2DHP/ mice (Sinnegger-Brauns et al. 2004). The calcium channel agonist Bay K 8644 as well as isradipine were without effect on ICa of CaV1.2DHP/ islet cells. The glucose-dependent insulin secretion was not DHP sensitive in this mouse model, substantiating the suggestion that CaV1.3 does not contribute to calcium channel current and insulin secretion in B-cells of the mouse. However, different CaV1.3 splice forms have been cloned from human B-cells, from rat RINm5F insulinoma cells and from the hamster insulin-secreting cell line HIT (Seino et al. 1992; Yaney et al. 1992; Ihara et al. 1995). In accordance with these findings, we found CaV1.3 transcripts in some of the B-cells, but no CaV1.3-related current. This could either be due to the absence of CaV1.3 protein or due to inactive CaV1.3 channels despite their expression in B-cells. Other groups demonstrated the presence of CaV1.3 subunit mRNAs and proteins in mouse pancreatic islet cells (Yang et al. 1999; Namkung et al. 2001). CaV1.3/ mice had a decreased number and size of islets. It was speculated about a putative connection between the levels of CaV1.3 gene expression and a transcriptional regulation (Yang et al. 1999). Furthermore, mutant islets secreted less insulin than control islets only in the presence of 3 mM glucose, a concentration at which wild-type A-cells are highly active in secreting glucagon. Thus, the decreased insulin secretion could be explained by a loss of glucagon release owing to the deletion of CaV1.3 in A-cells. This is in agreement with our finding that CaV1.3 current is only found in A-cells.
The expression of non-L-type calcium channels in islet cells has been discussed with controversy. The discrepances were raised, in part, by interspecies differences. Thus, for rat B-cells, P- and N-type calcium channels have been described (Komatsu et al. 1989; Ramanadham & Turk, 1994), whereas in humans, N-type calcium channels are either absent or represent a very minor component (Pollo et al. 1993; Davalli et al. 1996). In accordance with our findings, the expression of P/Q-, N- and R-type Ca2+ currents was postulated in mice B-cells by different authors (Schulla et al. 2003; Takahashi et al. 2005). For A-cells, very little is known about the expression of non-L-type HVA channels. Here we show that 30% of the A-cell IBa could be blocked by the CaV2.3 calcium channel blocker SNX 482. Thus, the R-type current represents the second dominant calcium channel in A-cells of mice, and one can assume that it plays a considerable role in glucagon secretion. Indeed in CaV2.3 deficient mice, the glucagon release was severely disturbed (Jing et al. 2005). In rat A-cells, an N-type calcium channel with an atypical reversible inhibition by
-conotoxin GVIA was found (Gromada et al. 1997). In mice A-cells, the IBa and the glucagon secretion could be inhibited by the N-type calcium channel blocker (Barg et al. 2000; Gopel et al. 2004). In our hands, mouse A-cells do not express N-type calcium channels. This discrepancy could be explained by the different methods of distinguishing A- from B-cells. In the present work, A- and B-cells were unequivocally identified after the patch-clamp experiments by single-cell RT-PCR with glucagon-specific primer pairs. Others describe and base their identification on the expression of a TTX-sensitive voltage-gated sodium current in A-cells, which, in contrast to its counterpart in B-cells, remains able to be activated at physiological membrane potentials (Gopel et al. 1999, 2004; Barg et al. 2000; Lou et al. 2003; Jing et al. 2005). In an elegant recent study, B-cells that expressed GFP under the mouse insulin promotor were identified by green fluorescence (Leung et al. 2005). In agreement with our experiments, the residual sodium current was not found in single A-cells. In contrast to our experiments, fluorescent B-cells only expressed the early inactivating sodium current in single cells and whole islets. The residual sodium current was identified in non-green (probably A-cells) of whole islets by Leung et al. (2005). The discrepancies may be caused by the following facts. (1) The early inactivating sodium current of B-cells has a high amplitude that may make it difficult to detect the relative small residual sodium current. (2) Islet cells which exclusively express the residual current are rare. One can speculate that, similar to A-cells, they are located in the periphery of the islets and thus were easily mistaken for A-cells. (3) It cannot be excluded that A-cells also express a residual sodium current, which according to Leung et al. (2005) got lost during the isolation procedure. (4) The MIP-GFP mice from the study of Leung et al. (2005) are transgenic mice. One hundred per cent of green cells were positively stained for insulin, but it is not clear how many of the non-green fluorescent cells were insulin positive. (5) In addition, in whole islets it was difficult to distinguish the non-green from the green fluorescent cells (Leung et al. 2005). (6) The differences could be due to the use of different mouse strains. Differences in metabolism have been reported between C57BL6, DBA/2, 129T2, ICR, FVB/n, MRL/MP and BALB/c (Andrikopoulos et al. 2005; Burgess et al. 2005; Gurley et al. 2006).
Direct experimental data on LVA calcium channels in islet cells are sparse, owing to the large HVA currents hiding the LVA currents combined with the lack of highly specific T-type calcium channel blockers. In mice, T-type channels have only been measured in intact pancreatic islets with the perforated patch-clamp technique (Gopel et al. 2000), whereas in isolated cells they were absent (Barg et al. 2000). Otherwise, T-type channels have only been described in insulinoma cell lines like INS-1, HIT-T15 and NIT-1. In the cardiac system, T-type calcium channel expression shows a spatial and temporal dependence (for review see Perez-Reyes, 2003). The currents are detectable in neonatal animals, increasing slightly to a peak between postnatal days 4 and 8, and then decline slowly to a steady state. In pathological conditions, such as hypertrophy, they reappear (Richard et al. 1998). In coronary artery and aortic smooth muscle, LVA currents were only detected when cells were cultured and proliferating (Rodman et al. 2005). Thus, it could be speculated that in certain tissue LVA calcium currents are not expressed under normal physiological conditions, but might play a role in proliferation and/or pathological state. In accordance with these results, it has been reported that the expression of LVA currents in mouse B-cells could be stimulated by cytokine treatment (Wang et al. 1996). For an islet cell, accustomed to being surrounded by neighbours, an existence in isolation is likely to be as abnormal as it gets. A likely explanation would be that gene transcription is influenced by paracrine signalling, which only operates in the intact islet. This notion was supported by the fact that mRNA for all known T-type channels has been found in whole islet tissue and in insulinoma cell lines. Alternatively, it may simply reflect the expression of T-type channels in cells other than A- and B-cells in the islet of Langerhans, since islet tissue contains four types of endocrine cells as well as nerve endings and capillaries.
Secretion of insulin and glucagon depends on different ion channel interplay
A- and B-cells show a competely different behaviour depending on the serum glucose level. High blood sugar levels induce a bursting activity in B-cells and silence A-cells. Glucagon secretion and A-cell activity is highest in the presence of low blood glucose. In both cell types, influx of extracellular Ca2+ through L-type calcium channels triggers hormone secretion. Therefore, the glucose concentration must be signalled to the L-type calcium channels through different mechanisms. It is assumed that at least two or three voltage-gated calcium channel types with different activating thresholds co-operate during Ca2+-triggered insulin release and that glucagon release is controlled by different channels (Pereverzev et al. 2002; Barg, 2003; Schulla et al. 2003). According to this hypothesis, we found a different distribution of HVA calcium and sodium channels in mouse A- and B-cells. Thus, the model of Pereverzev et al. (2002) concerning the successive activation of the KATP channel, and low-, middle- and high-voltage-activated calcium channels to trigger insulin release, could be modified. In both A- and B-cells of the mouse, T-type channels are not involved in hormone secretion under normal conditions. Since the residual sodium channel was found in a subpopulation of B-cells, closure of KATP channels in response to elevated glucose levels may result in the activation of those channels. Thus, it seems possible that the sodium current contributes to the calcium current-induced action potentials which spread over the remaining B-cells. In addition, it was shown that the sodium channel agonist veratridine and a scorpion toxin, TsTx-V, modulated the electrical activity in mouse pancreatic B-cells (Eberhardson & Grapengiesser, 1999; Goncalves et al. 2003). Also the involvement of transient receptor potential (TRP) channels cannot be excluded, since the involvement of non-selective cation currents provides an excellent mechanism for oscillatory calcium response (Qian et al. 2002). In accordance with this, TRPC4 was detected in islets by RT-PCR analysis. Studies on TRPC4-deficient mice are on-going to reveal their possible functions in pancreatic islets (Freichel et al. 2005). The fractions of the CaV2.1, CaV2.2 and CaV2.3 currents in B-cells are low compared to the whole calcium current, and a direct participation of these channels in first phase insulin secretion has not been proven to date. Thus, in B-cells they seem to fulfill secondary tasks, such as refilling or mobilizing reserve granules (Schulla et al. 2003). Recently, it was found that CaV2.3 knockout mice lack the second phase of insulin secretion and show markedly reduced glucose tolerance, impaired insulin release and stress-induced hyperglycaemia (Matsuda et al. 2001; Pereverzev et al. 2002; Jing et al. 2005).
In A-cells, the same amount of current as in B-cells traverses via L-type calcium channels, but A-cells express CaV1.2 and CaV1.3. Similar to B-cells, CaV2.1 currents amount to 15%. CaV2.2 currents are not detectable, whereas 30% of the calcium current was inhibited by the CaV2.3 blocker SNX 482. R-type currents show a voltage dependence between T- and L-type channels (Randall & Tsien, 1995; Tottene et al. 1996). In A-cells, the number of KATP channels is low and the membrane potential is partly depolarized in the absence of glucose (Gopel et al. 2000). Therefore, we speculated that in the presence of low glucose, CaV2.3 depolarizes the membrane potential sufficiently to activate CaV1.3 and subsequently CaV1.2 calcium channels. Alternatively, it was demonstrated earlier that neither isradipine nor SNX 482 inhibited glucagon secretion in the presence of low glucose levels in mouse islets. Both compounds impaired the ability of glucose to suppress glucagon secretion (Gopel et al. 2004; Jing et al. 2005). These results suggest that CaV1.2 and CaV2.3 are more likely to be associated with the prevention of glucagon release than with the release itself. In agreement with this, it has been found that glucagon secretion from rat A-cells is mediated by GABA release from neighbouring B-cells. GABA receptors have only been identified in A- but not in B-cells. Thus, the paradoxical stimulation of glucagon secretion by isradipine reflects the inhibition of GABA secretion due to the block of L-type calcium channels in B-cells (Wendt et al. 2004).
Conclusion
An increase in intracellular [Ca2+] is caused, in part, by the influx of Ca2+ through voltage-dependent calcium channels. Numerous studies have shown that multiple voltage-gated calcium channels, but also sodium and potassium channels are expressed in insulin-secreting B- and glucagon-secreting A-cells. Most of these studies on hormone secretion in islet cells were rather indirect, and an unequivocal allocation of the effects of different ion channels was hampered by the fact that A- and B-cells could not be distinguished beyond doubt by electrophysiological methods. Our approach, combining electrophysiology with PCR, clearly shows that HVA calcium channels and sodium channels are distributed differently in A- and B-cells of mouse pancreatic islets. Thus, in B-cells, CaV1.2, CaV2.1, CaV2.2, CaV2.3 and NaV1.7 currents are found, whereas A-cells express CaV1.2, CaV1.3, CaV2.1, CaV2.3 and NaV1.7 currents. LVA currents could be identified in none of the cells. These results could form the basis for further analysis of hormone secretion in islets in both healthy and diseased states.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Ashcroft FM, Proks P, Smith PA, Ammala C, Bokvist K & Rorsman P (1994). Stimulus-secretion coupling in pancreatic beta cells. J Cell Biochem 55 (Suppl.), 5465.[CrossRef][Medline]
Ashcroft FM & Rorsman P (1989). Electrophysiology of the pancreatic beta-cell. Prog Biophys Mol Biol 54, 87143.[CrossRef][Medline]
Barg S (2003). Mechanisms of exocytosis in insulin-secreting B-cells and glucagon-secreting A-cells. Pharmacol Toxicol 92, 313.[CrossRef][Medline]
Barg S, Galvanovskis J, Gopel SO, Rorsman P & Eliasson L (2000). Tight coupling between electrical activity and exocytosis in mouse glucagon-secreting alpha-cells. Diabetes 49, 15001510.[Abstract]
Barg
S, Ma
X, Eliasson
L, Galvanovskis
J, Gopel
SO, Obermuller
S
et al. (2001). Fast exocytosis with few Ca2+ channels in insulin-secreting mouse pancreatic B cells. Biophys J
81, 33083323.
Bean BP (1985). Two kinds of calcium channels in canine atrial cells. Differences in kinetics, selectivity, and pharmacology. J Genl Physiol 86, 130.[CrossRef]
Bech-Hansen NT, Naylor MJ, Maybaum TA, Pearce WG, Koop B, Fishman GA et al. (1998). Loss-of-function mutations in a calcium-channel alpha1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness. Nat Genet 19, 264267.[CrossRef][Medline]
Bokvist K, Olsen HL, Hoy M, Gotfredsen CF, Holmes WF, Buschard K et al. (1999). Characterisation of sulphonylurea and ATP-regulated K+ channels in rat pancreatic A-cells. Pflugers Arch 438, 428436.[CrossRef][Medline]
Bourinet E, Soong TW, Sutton K, Slaymaker S, Mathews E, Monteil A et al. (1999). Splicing of alpha 1A subunit gene generates phenotypic variants of P- and Q-type calcium channels. Nat Neurosci 2, 407415.[CrossRef][Medline]
Burgess
SC, Jeffrey
FM, Storey
C, Milde
A, Hausler
N, Merritt
ME
et al. (2005). Effect of murine strain on metabolic pathways of glucose production after brief or prolonged fasting. Am J Physiol Endocrinol Metab
289, E53E61.
Curry DL, Bennett LL & Grodsky GM (1968). Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology 83, 572584.[Medline]
Davalli AM, Biancardi E, Pollo A, Socci C, Pontiroli AE, Pozza G et al. (1996). Dihydropyridine-sensitive and -insensitive voltage-operated calcium channels participate in the control of glucose-induced insulin release from human pancreatic beta cells. J Endocrinol 150, 195203.[Abstract]
Eberhardson M & Grapengiesser E (1999). Role of voltage-dependent Na+ channels for rhythmic Ca2+ signalling in glucose-stimulated mouse pancreatic beta-cells. Cell Signal 11, 343348.[CrossRef][Medline]
Freichel
M, Vennekens
R, Olausson
J, Stolz
S, Philipp
SE
et al. (2005). Functional role of TRPC proteins in native systems: implications from knockout and knock-down studies. J Physiol
567, 5966.
Goldin AL, Barchi RL, Caldwell JH, Hofmann F, Howe JR, Hunter JC et al. (2000). Nomenclature of voltage-gated sodium channels. Neuron 28, 365368.[CrossRef][Medline]
Goncalves AA, Toyama MH, Carneiro EM, Marangoni S, Arantes EC et al. (2003). Participation of Na+ channels in the potentiation by Tityus serrulatus alpha-toxin TsTx-V of glucose-induced electrical activity and insulin secretion in rodent islet beta-cells. Toxicon 41, 10391045.[Medline]
Gopel
S, Kanno
T, Barg
S, Galvanovskis
J
&
Rorsman
P (1999). Voltage-gated and resting membrane currents recorded from B-cells in intact mouse pancreatic islets. J Physiol
521, 717728.
Gopel
SO, Kanno
T, Barg
S, Weng
XG, Gromada
J
&
Rorsman
P (2000). Regulation of glucagon release in mouse -cells by KATP channels and inactivation of TTX-sensitive Na+ channels. J Physiol
528, 509520.
Gopel
S, Zhang
Q, Eliasson
L, Ma
XS, Galvanovskis
J, Kanno
T
et al. (2004). Capacitance measurements of exocytosis in mouse pancreatic
-, ß- and
-cells within intact islets of Langerhans. J Physiol
556, 711726.
Gromada
J, Bokvist
K, Ding
WG, Barg
S, Buschard
K
et al. (1997). Adrenaline stimulates glucagon secretion in pancreatic A-cells by increasing the Ca2+ current and the number of granules close to the L-type Ca2+ channels. J Gen Physiol
110, 217228.
Gurley
SB, Clare
SE, Snow
KP, Hu
A, Meyer
TW
&
Coffman
TM (2006). Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol
290, F214F222.
Henquin JC, Ravier MA, Nenquin M, Jonas JC & Gilon P (2003). Hierarchy of the beta-cell signals controlling insulin secretion. Eur J Clin Invest 33, 742750.[CrossRef][Medline]
Herrera PL (2000). Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development 127, 23172322.[Abstract]
Ihara Y, Yamada Y, Fujii Y, Gonoi T, Yano H, Yasuda K et al. (1995). Molecular diversity and functional characterization of voltage-dependent calcium channels (CACN4) expressed in pancreatic beta-cells. Mol Endocrinol 9, 121130.[Abstract]
Iwashima Y, Pugh W, Depaoli AM, Takeda J, Seino S et al. (1993). Expression of calcium channel mRNAs in rat pancreatic islets and downregulation after glucose infusion. Diabetes 42, 948955.[Abstract]
Jing X, Li DQ, Olofsson CS, Salehi A, Surve VV, Caballero J et al. (2005). CaV2.3 calcium channels control second-phase insulin release. J Clin Invest 115, 146154.[CrossRef][Medline]
Komatsu M, Yokokawa N, Takeda T, Nagasawa Y, Aizawa T & Yamada T (1989). Pharmacological characterization of the voltage-dependent calcium channel of pancreatic B-cell. Endocrinology 125, 20082014.[Abstract]
Koschak
A, Reimer
D, Huber
I, Grabner
M, Glossmann
H
et al. (2001). alpha 1D (CaV1.3) subunits can form L-type Ca2+ channels activating at negative voltages. J Biol Chem
276, 2210022106.
Kotturi MF & Jefferies WA (2005). Molecular characterization of L-type calcium channel splice variants expressed in human T lymphocytes. Mol Immunol 42, 14611474.[CrossRef][Medline]
Leung
YM, Ahmed
I, Sheu
L, Tsushima
RG, Diamant
NE
et al. (2005). Electrophysiological characterization of pancreatic islet cells in the mouse insulin promoter-green fluorescent protein mouse. Endocrinology
146, 47664775.
Lou
XL, Yu
X, Chen
XK, Duan
KL, He
LM, Qu
A
et al. (2003). Na+ channel inactivation: a comparative study between pancreatic islet ß-cells and adrenal chromaffin cells in rat. J Physiol
548, 191202.
McCleskey
EW, Fox
AP, Feldman
DH, Cruz
LJ, Olivera
BM
et al. (1987).
-conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle. Proc Natl Acad Sci U S A
84, 43274331.
Matsuda Y, Saegusa H, Zong S, Noda T & Tanabe T (2001). Mice lacking CaV2.3 (alpha 1E) calcium channel exhibit hyperglycemia. Biochem Biophys Res Commun 289, 791795.[CrossRef][Medline]
Mears D (2004). Regulation of insulin secretion in islets of Langerhans by Ca2+ channels. J Membr Biol 200, 5766.[CrossRef][Medline]